摘要
目的:探究分析双歧杆菌三联活菌散在早产儿坏死性小肠结肠炎治疗中的应用效果。方法:随机选取我院在2017年8月-2018年8月期间收治的80例早产儿坏死性小肠结肠炎患儿为研究对象,并将其分为观察组(n=40)和对照组(n=40),其中对照组患儿采用常规临床方案治疗,观察组患儿在常规治疗的基础上增加双歧杆菌三联活菌散治疗,对比观察两组临床治疗效果。结果:观察组患儿临床症状好转时间(12.22±2.03)d和住院时间(20.43±3.06)d均明显短于对照组(15.33±4.27)d、(25.74±3.92)d,且观察组患儿临床治疗有效率(95.00%)明显高于对照组(20.00%),两组比较具有统计学意义(P<0.05)。结论:坏死性结肠炎早产儿采用双歧杆菌三联活菌散治疗的疗效确切,能够有效缩短康复时间,值得临床推广应用。
Objective:To explore and analyze the effect of Bifidobacterium triple viable powder in the treatment of necrotizing enterocolitis in premature infants.Methods:80 cases of premature infants with necrotizing enterocolitis treated in our hospital from August 2017 to August 2018 were randomly divided into observation group(n=40)and control group(n=40).The control group was treated with routine clinical regimen,and the observation group was treated with bifidus on the basis of routine treatment.Bacilli triple viable powder treatment,compared the clinical efficacy of the two groups.Results:The improvement time of clinical symptoms and hospitalization time of observation group were significantly shorter than those of control group(15.33(+4.27)days and(25.74(+3.92)days,and the effective rate of clinical treatment in observation group(95.00%)was significantly higher than that of control group(20.00%).There was significant difference between the two groups(P<0.05).Conclusion:Bifidobacterium triple viable powder is effective in the treatment of premature infants with necrotizing colitis,which can effectively shorten the recovery time and is worthy of clinical application.
出处
《现代消化及介入诊疗》
2018年第A02期28-28,共1页
Modern Interventional Diagnosis and Treatment in Gastroenterology
关键词
双歧杆菌三联活菌散
早产儿
结肠炎
Bifidobacterium triple viable powder
premature infant
colitis
